HF
STIM icon

HRT Financial’s Neuronetics STIM Stock Holding History

HRT Financial’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Sell
88,710
-11,910
-12% -$17.3K ﹤0.01% 3573
2026
Q1 		$145K Buy
+100,620
New +$159K ﹤0.01% 3273
2025
Q2 		– Sell
-94,870
Closed -$349K – 3481
2025
Q1 		$349K Buy
+94,870
New +$346K ﹤0.01% 1688
2021
Q2 		– Sell
-48,806
Closed -$603K – 3502
2021
Q1 		$603K Buy
+48,806
New +$748K 0.01% 1637

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HRT Financial's STIM Position: Q2 2026 in Review

HRT Financial reduced its Neuronetics (STIM) stake by 12% in Q2 2026, selling an estimated $17.3K and leaving 88,710 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #3573.

HRT Financial first reported a position in STIM in Q1 2021 and has held it in 4 quarters since. The position peaked at $603K in Q1 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • HRT Financial held 88,710 shares of Neuronetics worth $115K as of Q2 2026.
  • HRT Financial sold 11,910 Neuronetics shares in Q2 2026, an estimated $17.3K.
  • Neuronetics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3573 holding.
  • HRT Financial first reported a position in Neuronetics in Q1 2021 and has held it in 4 quarters since.
  • HRT Financial's Neuronetics position peaked at $603K in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.